Researchers analyse the efficacy of immunotherapy combined with chemotherapy in the treatment of early breast cancer
Researchers from the Clínic-IDIBAPS have coordinated a study that analyses the efficacy of anti-PD-1/PD-L1 immune checkpoint inhibitors (ICIs) combin1